Page 63 - IMO-1-1

Innovative Medicines & Omics Antioxidant nanomedicines for therapies

225. Hely MA, Fung VS, Morris JG. Treatment of Parkinson’s Ozawa T, Watanabe Y. Edaravone and cyclosporine A as
disease. J Clin Neurosci. 2000;7(6):484-494. neuroprotective agents for acute ischemic stroke. Acute
Med Surg. 2018;5(3):213-221.
doi: 10.1054/jocn.2000.0766
doi: 10.1002/ams2.343
226. Kwon HJ, Kim D, Seo K, et al. Ceria nanoparticle systems
for selective scavenging of mitochondrial, intracellular, 238. Lapchak PA. A critical assessment of edaravone acute
and extracellular reactive oxygen species in Parkinson’s ischemic stroke efficacy trials: Is edaravone an effective
disease. Angew Chem Int Ed Engl. 2018;57(30):9408-9412. neuroprotective therapy? Expert Opin Pharmacother.
doi: 10.1002/anie.201805052 2010;11(10):1753-1763.
227. Hao C, Qu A, Xu L, et al. Chiral molecule-mediated porous doi: 10.1517/14656566.2010.493558
Cu (x)O nanoparticle clusters with antioxidation activity 239. He W, Mei Q, Li J, et al. Preferential targeting cerebral
for ameliorating Parkinson’s disease. J Am Chem Soc. ischemic lesions with cancer cell-inspired nanovehicle for
2019;141(2):1091-1099. ischemic stroke treatment. Nano Lett. 2021;21(7):3033-3043.
doi: 10.1021/jacs.8b11856 doi: 10.1021/acs.nanolett.1c00231
228. Li Q, Barres BA. Microglia and macrophages in brain homeostasis 240. Wang C, Wu B, Wu Y, Song X, Zhang S, Liu Z.
and disease. Nat Rev Immunol. 2018;18(4):225-242. Camouflaging nanoparticles with brain metastatic tumor
doi: 10.1038/nri.2017.125 cell membranes: A new strategy to traverse blood-brain
barrier for imaging and therapy of brain tumors. Adv Funct
229. Liu H, Han Y, Wang T, et al. Targeting microglia for therapy Mater. 2020;30(14):1909369.
of Parkinson’s disease by using biomimetic ultrasmall
nanoparticles. J Am Chem Soc. 2020;142(52):21730-21742. doi: 10.1002/adfm.201909369
doi: 10.1021/jacs.0c09390 241. Liu Y, Ai K, Ji X, et al. Comprehensive insights into the
multi-antioxidative mechanisms of melanin nanoparticles
230. Feng W, Han X, Hu H, et al. 2D vanadium carbide and their application to protect brain from injury in
MXenzyme to alleviate ROS-mediated inflammatory ischemic stroke. J Am Chem Soc. 2017;139(2):856-862.
and neurodegenerative diseases. Nat Commun.
2021;12(1):2203. doi: 10.1021/jacs.6b11013
doi: 10.1038/s41467-021-22278-x 242. Kim CK, Kim T, Choi IY, et al. Ceria nanoparticles that can
protect against ischemic stroke. Angew Chem Int Ed Engl.
231. Palikaras K, Lionaki E, Tavernarakis N. Mechanisms 2012;51(44):11039-11043.
of mitophagy in cellular homeostasis, physiology and
pathology. Nat Cell Biol. 2018;20(9):1013-1022. doi: 10.1002/anie.201203780
doi: 10.1038/s41556-018-0176-2 243. Bao Q, Hu P, Xu Y, et al. Simultaneous blood-brain
barrier crossing and protection for stroke treatment
232. Youle RJ, Narendra DP. Mechanisms of mitophagy. Nat Rev
Mol Cell Biol. 2011;12(1):9-14. based on edaravone-loaded ceria nanoparticles. ACS
Nano. 2018;12(7):6794-6805.
doi: 10.1038/nrm3028
doi: 10.1021/acsnano.8b01994
233. Li B, Bai Y, Yion C, et al. Single-atom nanocatalytic therapy for
suppression of neuroinflammation by inducing autophagy of 244. He L, Huang G, Liu H, Sang C, Liu X, Chen T.
abnormal mitochondria. ACS Nano. 2023;17(8):7511-7529. Highly bioactive zeolitic imidazolate framework-
8-capped nanotherapeutics for efficient reversal of
doi: 10.1021/acsnano.2c12614 reperfusion-induced injury in ischemic stroke. Sci Adv.
234. Campbell BCV, De Silva DA, Macleod MR, et al. Ischaemic 2020;6(12):eaay9751.
stroke. Nat Rev Dis Primers. 2019;5(1):70. doi: 10.1126/sciadv.aay9751
doi: 10.1038/s41572-019-0118-8 245. Li S, Jiang D, Ehlerding EB, et al. Intrathecal administration
235. Medcalf RL, Davis SM. Plasminogen activation and thrombolysis of nanoclusters for protecting neurons against oxidative
for ischemic stroke. Int J Stroke. 2012;7(5):419-425. stress in cerebral ischemia/reperfusion injury. ACS
Nano. 2019;13(11):13382-13389.
doi: 10.1111/j.1747-4949.2012.00783.x
doi: 10.1021/acsnano.9b06780
236. Allen CL, Bayraktutan U. Oxidative stress and its role in the
pathogenesis of ischaemic stroke. Int J Stroke. 2009;4(6):461-470. 246. Wang Z, Zhao Y, Hou Y, et al. A thrombin-activated
peptide-templated nanozyme for remedying ischemic
doi: 10.1111/j.1747-4949.2009.00387.x stroke via thrombolytic and neuroprotective actions. Adv
237. Matsumoto S, Murozono M, Kanazawa M, Nara T, Mater. 2023:e2210144.

Volume 1 Issue 1 (2024) 57 doi: 10.36922/imo.2527